AGA Clinical Guidelines on Management of Moderate to Severe Ulcerative Colitis: Accompanying Educational Presentation
JAK Inhibitors for Ulcerative Colitis: Conversations From the Clinic
Emerging evidence for S1P receptor modulators in ulcerative colitis
Gastrointestinal toxicities from cancer immunotherapy
Positioning of new S1P receptor modulators to optimize patient outcomes in UC